Chemokine receptor antagonists: novel therapeutics for inflammation and AIDS

References

• OPPENHEIM JJ, ZACHARIAE CO, MUKAIDA N, MAT-SUSHIMA K: Properties of the novel proinflammatory supergene `intercrine' cytokine family. Ann. Rev. Im-munol. (1991) 9:617–648.
   PubMed Web of Science ®Google Scholar
• GRAHAM GJ, WRIGHT EG, HEWICK R et al.: Identifica-tion and characterization of an inhibitor of haemo-p oi et ic stem cell proliferation. Nature (1990) 344:442–444.
   PubMed Web of Science ®Google Scholar
• BROXMEYER HE, SHERRY B, LU L et al.: Enhancing andsuppressing effects of recombinant macrophage in-flammatory proteins on colony formation in vitro by bone marrow myeloid progenitor cells. Blood (1990) 76:1110–1116.
   PubMed Web of Science ®Google Scholar
• COOK DN: The role of MIP-1 alpha in inflammationand hematopoiesis. J. Leukoc. Biol. (1996) 59(1):61–66.
   PubMed Web of Science ®Google Scholar
• NAGASAWA T, HIROTA S, TACHIBANA K et al.: Defects ofB-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Na-ture (1996) 382:635–638.
   PubMed Web of Science ®Google Scholar
• SARRIS AH, BROXMEYER HE, WIRTHMUELLER U et at.:Human interferon-inducible protein 10: expression and purification of recombinant protein demonstrate inhibition of early human hematopoietic progenitors. J. Exp. Med. (1993) 178:1127–1132.
   Google Scholar
• KOCH AE, POLVERINI PJ, KUNKEL SL et al.: Interleukin-8as a macrophage-derived mediator of angiogenesis. Science (1992) 258: 1798-1801.
   Google Scholar
• STRIETER RM, KUNKEL SL, ARENBERG DA, BURDICK MD,POLVERINI PJ: Interferon gamma-inducible protein 10 (IP-10), a member of the C-X-C chemokine family, is an inhibitor of angiogenesis. Biochem. Biophys. Res. Com-mun. (1995) 210:51–57.
   PubMed Web of Science ®Google Scholar
• CAO Y, CHEN C, WEATHERBEE JA, TSANG M, FOLKMAN J:Gro-beta, a -C-X-C- chemokine, is an angiogenesis in-hibitor that suppresses the growth of Lewis lung carci-noma in mice. J. Exp. Med. (1995) 182:2069–2077.
   PubMed Web of Science ®Google Scholar
• VAN SNICK, J, HOUSSIAU F, PROOST P, VAN DAMME J,RENAULD JC: I-309/T cell activation gene 3 chemokine protects murine T cell lymphomas against dexametha-sone induced apoptosis. J. Immunol. (1996) 157:2570–2576.
   PubMed Web of Science ®Google Scholar
• COOK DN, BECK MA, COFFMAN TM et al.: Requirementof MIP-la for an inflammatory response to viral infec-tion. Science (1995) 269:1583–1585.
   PubMed Web of Science ®Google Scholar
• COCCHI F, DEVICO AL, GARZINO-DEMO A et al.: Identifi-cation of RANTES, MIP-la and MIP-113 as the major HIV-suppressive factors produced by CD8+ T cells. Sci-ence (1995) 270: 1811-1815.
   Google Scholar
• KELNER GS, KENNEDY J, BACON KB et al.: Lymphotac-tin: a novel cytokine which represents a new class of chemokine. Science (1994) 266:1395–1359.
   PubMed Web of Science ®Google Scholar
• KENNEDY J, KELNER GS, KLEYENSTEUBER S et al.: Mo-lecular cloning and functional characterization of hu-man lymphotactin. J. Immunot (1995) 155:203–209.
   Google Scholar
• BAZAN F, BACON K, HARDIMAN G et al.: A new class ofmembrane-bound chemokine with a CX3C motif. Na-ture (1997) 385:640–644.
   PubMed Web of Science ®Google Scholar
• PAN Y, LLOYD C, ZHOU H et al.: Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation. Nature (1997) 387:611–617.
   PubMed Web of Science ®Google Scholar
• MURPHY PM: The molecular biology of leukocyte che-moattractant receptors. Ann. Rev. Immunol, (1994) 12:593–633.
   PubMed Web of Science ®Google Scholar
• LOETSCHER P, SEITZ M, BAGGIOLINI M, MOSER B:Interleukin-2 regulates CC chemokine receptor ex-pression and chemotactic responsiveness in T-lymphocytes. J. Exp. Med. (1996) 184:569–577.
   PubMed Web of Science ®Google Scholar
• LUKACS NW, STRIETER RM, SHAKLEE CL, CHENSUE SW,KUNKEL SL: Macrophage inflammatory protein-1 al-pha influences eosinophil recruitment in antigen-specific airway inflammation. Eur, J. Immunot (1995) 25:245–251.
   PubMed Web of Science ®Google Scholar
• BROADDUS VC, BOYLAN AM, HOEFFEL JM et al.: Neu-tralization of IL-8 inhibits neutrophil influx in a rabbit model of endotoxin-induced pleurisy. J. Immunot (1994) 152:2960–2967.
   Google Scholar
• MULLIGAN MS, JONES ML, BOLANOWSKI MA et al.: Inhi-bition of lung inflammatory reactions in rats by an anti-human IL-8 antibody. J. Immunol, (1993) 150:5585–5595.
   PubMed Web of Science ®Google Scholar
• FLORY CM, JONES ML WARREN JS: Pulmonary granu-loma formation in the rat is partially dependent on monocyte chemoattractant protein 1. tab. Invest. (1993) 69:396–404.
   Google Scholar
• RAND ML, WARREN JS, MANSOUR MK, NEWMAN W, RINGLER DJ: Inhibition of T-cell recruitment and cuta-neous delayed-type hypersensitivity-induced inflam-mation with antibodies to monocyte chemoattractant protein-1. Am. J. PathoL (1996) 148:855–864.
   PubMed Web of Science ®Google Scholar
• VANOTTEREN GM, STRIETER RM, KUNKEL SL et al.: Com-partmentalized expression of RANTES in a murine model of endotoxemia. J. Immunot (1995) 154:1900–1908.
   Google Scholar
• GAO JL, WYNN TA, CHANG Y et al.: Impaired host de-fense, hematopoiesis, granulomatous inflammation and type 1-type2 cytokine balance in mice lacking CC chemokine receptor 1. J. Exp. Med. (1997) 185:1959–1968.
   PubMed Web of Science ®Google Scholar
• KUZIEL WA, MORGAN SJ, DAWSON TC et al.: Severe re-duction in leukocyte adhesion and monocyte extra-vasation in mice deficient in CC chemokine receptor 2. Proc. Natl. Acad. Sci, USA (1997) 94:12053–12058.
   PubMed Web of Science ®Google Scholar
• CACALANO G, LEE J, KIKLY K et al.: Neutrophil and B-cellexpansion in mice that lack the murine IL-8 receptor homolog. Science (1994) 265:682–684.
   PubMed Web of Science ®Google Scholar
• ZAGORSKI J, WAHL SM: Inhibition of acute peritonealinflammation in rats by a cytokine induced neutrophil chemoattractant receptor antagonist. J. Immunol, (1997) 159:1059–1062.
   PubMed Web of Science ®Google Scholar
• GONG JH, RATKAY LG, WATERFIELD JD, CLARK-LEWIS I:An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL-/pr mouse model. J. Exp. Med. (1997) 186:131–137.
   PubMed Web of Science ®Google Scholar
• CLARK-LEWIS I, SCHUMACHER C, BAGGIOLINI M, MOSERB: Structure-activity relationships of interleukin-8 de-termined using chemically synthesized analogs: criti-cal role of Nib-terminal residues and evidence for uncoupling of neutrophil chemotaxis, exocytosis and receptor binding activities. J. Biol. Chem. (1991) 266:23128–23134.
   PubMed Web of Science ®Google Scholar
• HEBERT CA, VITANGCOL RV, BAKER JB: Scanning muta-genesis of interleukin-8 identifies a cluster of residues required for receptor binding. J. Blot Chem. (1991) 266:18989–18994.
   PubMed Web of Science ®Google Scholar
• GAYLE RD, SLEATH PR, SRINIVASON S et al.: Importance of the amino terminus of the interleukin-8 receptor in ligand interactions. J. Blot Chem. (1993) 268:7283–7289.
   PubMed Web of Science ®Google Scholar
• LAROSA GJ, THOMAS KM, KAUFMANN ME et al.: Amino terminus of the interleukin-8 receptor is a major deter-minant of receptor subtype specificity. J. Blot Chem. (1992) 267:25402–25406.
   PubMed Web of Science ®Google Scholar
• MOSER B, DEWALD B, BARELLA L et al.: Interleukin-8 an-tagonists generated by N-terminal modification. J. Blot Chem. (1993) 268:7125–7128.
   PubMed Web of Science ®Google Scholar
• JONES SA, DEWALD B, CLARK-LEWIS I, BAGGIOLINI M:Chemokine antagonists that discriminate between interleukin-8 receptors. J. Blot Chem. (1997) 272:16166–16169.
   PubMed Web of Science ®Google Scholar
• CLARK-LEWIS I, DEWALD B, GEISER T, MOSER B, BAG-GIOLINI M: Interleukin-8 antagonists generated by N-terminal modification. Proc. Natl. Acad. Sci, USA (1993) 90:3574–3577.
   PubMed Web of Science ®Google Scholar
• WATANABE K, KOIZUMI F, KURASHIGE Y, TSURUFUJI S,NAKAGAWA H: Rat CINC, a member of the interleukin-8 family, is a neutrophil-specific chemoat-tractant in vivo. Exp. Mot Pathol, (1991) 55:30–37.
   PubMed Web of Science ®Google Scholar
• WEBER M, UGUCCIONI M, BAGGIOLINI M, CLARK-LEWIS I, DAHINDEN CA: Deletion of the Nib-terminal residue converts monocyte chemotactic protein 1 from an ac-tivator of basophil mediator release to an eosinophil chemoattractant. J. Exp. Med. (1996) 183:681–685.
   PubMed Web of Science ®Google Scholar
• GONG JH, CLARK LI: Antagonists of monocyte chemoat-tractant protein 1 identified by modification of func-tionally critical NH2-terminal residues. J. Exp. Med. (1995) 181:631–640.
   PubMed Web of Science ®Google Scholar
• ZHANG YJ, RUTLEDGE BJ, ROLLINS BJ: Structure/activity analysis of human monocyte chemoattractant protein-1 (MCP-1) by mutagenesis. Identification of a mutated protein that inhibits MCP-1-mediated mono-cyte chemotaxis. J. Biol. Chem. (1994) 269:15918–15924.
   Google Scholar
• ZHANG Y, ROLLINS BJ: A dominant negative inhibitor indicates that monocyte chemoattractant protein 1 functions as a dimer. Mot, Cell. Biol. (1995) 15:4851–4855.
   Web of Science ®Google Scholar
• GONG JH, UGUCCIONI M, DEWALD B, BAGGIOLINI M, CLARK-LEWIS I: RANTES and MCP-3 antagonists bind multiple chemokine receptors. J. Biol. Chem. (1996) 271:10521–10527.
   PubMed Web of Science ®Google Scholar
• PROUDFOOT AE, POWER CA, HOOGEWERF AJ et al.: Ex-tension of recombinant human RANTES by the reten-tion of the initiating methionine produces a potent antagonist. J. Biol. Chem. (1996) 271:2599–2603.
   PubMed Web of Science ®Google Scholar
• HEATH H, QIN S, RAO P et al.: Chemokine receptor us-age by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal anti-body. J. Clin, Invest. (1997) 99:178–184.
   Google Scholar
• PROUDFOOT AEI: Role of chemokine receptor antago-nists in inflammatory disease. Chemokine Receptors and Host Cell Interactions. Baltimore, MD, USA (1997).
   Google Scholar
• SIMMONS G, CLAPHAM PR, PICARD L et al.: Potent inhibi-tion of 11IV-1 infectivity in macrophages and lympho-cytes by a novel CR5 antagonist. Science (1997) 276:276–279.
   PubMed Web of Science ®Google Scholar
• ARENZANA-SELSDEDOS F, VIRELLZIER J, ROUSSET D etal.: HIV blocked by chemokine antagonist. Nature (1996) 383:400.
   Google Scholar
• ATCHISON RE, GOSLING J, MONTECLARO FS et al.: Multi-ple extracellular elements of CCR5 and 11IV-1 entry: dissociation from response to chemokines. Science (1996) 274: 1924-1926.
   Google Scholar
• FRADE JMR, LLORENTE M, MELLADO M et al.: The amino-terminal domain of the CCR2 chemokine receptor acts as a coreceptor for 11IV-1 infection. J. Din. Invest. (1997) 100:497–502.
   PubMed Web of Science ®Google Scholar
• RUCKER J, SAMSON M, DORANZ BJ et al.: Regions in 13-ch-emokine receptors CCR5 and CCR2b that determine 11IV-1 cofactor specificity. Cell (1996) 87:437–446.
   PubMed Web of Science ®Google Scholar
• DRAGIC T, LITWIN V, ALLAWAY GP et al.: 11IV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature (1996) 381:667–673.
   PubMed Web of Science ®Google Scholar
• ORAVECZ T, PALL M, NORCROSS MA: Beta-chemokine inhibition of monocytotropic 11IV-1 infection. Inter-ference with a postbinding fusion step. J. Immunol. (1996) 157:1329–1332.
   Google Scholar
• JONES SA, WOLF M, QIN S, MACKAY CR, BAGGIOLINI M: Different functions for the interleukin 8 receptors (IL-812) of human neutrophil leukocytes: NADPH oxidase and phospholipase D are activated through IL-8R1 but not IL-8R2. Proc. Natl. Acad. Sci, USA (1996) 93:6682–6686.
   PubMed Web of Science ®Google Scholar
• CHUNTHARAPAI A, LEE J, BURNIER J et al.: Neutralizing monoclonal antibodies to human IL-8 receptor: a map to the Nib-terminal region of the receptor. J. Immunol, (1994) 152:1783–1789.
   PubMed Web of Science ®Google Scholar
• CHUNTHARAPAI A, LEE J, HEBERT CA, KIM KJ: Mono-clonal antibodies detect different distribution patterns of IL-8 receptor A and IL-8 receptor B on human pe-ripheral blood leukocytes. J. Immunol, (1994) 153:5682–5688.
   PubMed Web of Science ®Google Scholar
• UGUCCIONI M, MACKAY CR, OCHENSBERGER B et al.:High expression of chemokine receptor CCR3 in human blood basophils. J. Din. Invest. (1997) 100:1137–1143.
   PubMed Web of Science ®Google Scholar
• SALLUSTO F, MACKAY CR, LANZAVECCHIA A: Selectiveexpression of the eotaxin receptor CCR3 by human T helper 2 cells. Science (1997) 277: 2005-2007.
   Google Scholar
• WU L, PAXTON WA, KASSAM N et al.: CCR5 levels and ex-pression pattern corelate with infectability by macrophage-tropic 11IV-1, in vitro. J. Exp. Med. (1997) 185:1681–1691.
   PubMed Web of Science ®Google Scholar
• WU L, LAROSA G, KASSAM N et al.: Interaction of che-mokine receptor CCR5 with its ligands: multiple do-mains for 11IV-1 gp120 binding and a single domain for chemokine binding. J. Exp. Med. (1997) 186:1373–1381.
   PubMed Web of Science ®Google Scholar
• SCHRAUFSTATTER UI: IL-8 receptor antagonists in in-flammation. Chemokines: Latest Advances in Understand-ing and Therapeutic Development. Baltimore, MD, USA (1997).
   Google Scholar
• MILLER EJ, KURDOWSKA A, NAGAO S et al.: A synthetic peptide which specifically inhibits heat treated interleukin-8 (IL-8) binding and chemotaxis for neu-trophils. Agents Actions (1993) 40:200–208.
   PubMedGoogle Scholar
• HAYASHI S, KURDOWSKA A, MILLER EJ et al.: Synthetic hexa- and heptapeptides that inhibit IL-8 from binding to and activating human blood neutrophils. J. Immu-nol, (1995) 154:814–824.
   PubMed Web of Science ®Google Scholar
• SCHOLS D, STRUYF S, VAN DAMME J et al.: Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4. J. Exp. Med. (1997) 186:1383–1388.
   Google Scholar
• MURAKAMI T, NAKAJIMA T, KOYANAGI Y et al.: A small molecule CXCR4 inhibitor that blocks T cell line-tropic 11IV-1 infection. J. Exp. Med. (1997) 186:1389–1393.
   PubMed Web of Science ®Google Scholar
• DORANZ BJ, GROVIT-FERBAS K, SHARRON MP et at.: A small-molecule inhibitor directed against the che-mokine receptor CXCR4 prevents its use as an HIV-1 co-receptor. J. Exp. Med. (1997) 186:1395–1400.
   Google Scholar
• O'BRIEN WA, SUMNER-SMITH M, MAO S-H et al.: Anti-human immunodeficiency virus type 1 activity of an oligocationic compound mediated via gp120 V3 inter-actions. J. Virol, (1996) 70:2825–2831.
   Google Scholar
• NEWTON RC: Identifcation of a small molecule antago-nist of human CCR2. Chemokines: Latest Advances in Un-derstanding and Therapeutic Development. Baltimore, MD, USA (1997).
   Google Scholar
• UGUCCIONI M, D'APUZZO M, LOETSCHER M, DEWALD B, BAGGIOLINI M: Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES, MIP-la and MIP-113 on human monocytes. Eur, J. Immunol, (1995) 25:64–68.
   Web of Science ®Google Scholar
• TAUB DD, PROOST P, MURPHY WJ et al.: Monocyte che-motactic protein-1 (MCP-1), -2 and -3 are chemotactic for human T lymphocytes. J. Din. Invest. (1995) 95:1370–1376.
   PubMed Web of Science ®Google Scholar
• LOETSCHER P, SEITZ M, CLARK LEWIS I, BAGGIOLINI M,MOSER B: Activation of NK cells by CC chemokines. Chemotaxis, Ca2+ mobilization and enzyme release. J. Immunol, (1996) 156:322–327.
   Google Scholar
• BEN-BARUCH A, XU L, YOUNG PR et al.: Monocyte che-motactic protein-3 (MCP-3) interacts with multiple leu-kocyte receptors. J. Biol. Chem. (1 9 9 5) 270 (16):22123–22128.
   Google Scholar
• GARCIA-ZEPADA EA, COMBADIERE C, ROTHENBERG ME et al.: Human monocyte chemoattractant protein (MCP)-4 is a novel chemokine with activityes on monocytes, eosinophils and basophils induced in al-lergic and non-allergic inflammation that signals through the CC chemokine receptors (CCR)-2 and -3. J. Immunol. (1996) 157:5613–5626.
   PubMed Web of Science ®Google Scholar
• SAMSON M, LABBE O, MOLLEREAU C, VASSART G, PAR-MENTIER M: Molecular cloning and functional expres-sion of a new human CC-chemokine receptor gene. Biochemistry (1996) 35:3362–3367.
   PubMed Web of Science ®Google Scholar
• NEOTE K, DIGREGORIO D, MAK JY, HORUK R, SCHALL TJ: Molecular cloning, functional expression and signal-ing characteristics of a C-C chemokine receptor. Cell (1993) 72:415–425.
   PubMed Web of Science ®Google Scholar
• RAPORT CJ, GOSLING J, SCHWEICKART VL, GRAY PW, CHARO IF: Molecular cloning and functional charac-terization of a novel human CC chemokine receptor (CCR5) for RANTES, MIP-113 and M1P-la. Biol. Chem. (1996) 271:17161–17166.
   Web of Science ®Google Scholar
• PONATH PD, QIN S, RINGLER DJ etal.: Cloning of the hu-man eosinophil chemoattractant, eotaxin: expres-sion, receptor binding and functional properties provide a mechanism for the selective recruitment of eosinophils. Din. Invest. (1996) 97:604–612.
   Google Scholar
• PONATH PD, QIN S, POST TW et al.: Molecular cloning and characterization of a human eotaxin receptor ex-pressed selectively on eosinophils. Exp. Med. (1996) 183:2437–2448.
   PubMed Web of Science ®Google Scholar
• IMAI T, BABA M, NISHIMURA M et al.: The T-cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J. Biol. Chem. (1997) 272:15036–15042.
   PubMed Web of Science ®Google Scholar
• IMAI T, YOSHIDA T, BABA M et al.: Molecular cloning of a novel T-cell-directed C chemokine expressed in thy-mus by signal sequence trap using Epstein-Barr virus vector. Biol Chem. (1996) 271:21514–21521.
   Web of Science ®Google Scholar
• BABA M, IMAI T, NISHIMURA M et al.: Identification of CCR6, the specific receptor for a novel lymphocyte- directed CC chemokine LARC.Biol. Chem. (1997)272:14893–14898.
   Google Scholar
• POWER CA, CHURCH DJ, MEYER A et al.: Cloning and characterization of a specific receptor for the novel CC chemokine MIP-3a from lung dendritic cells. J. Exp. Med. (1997) 186:825–835.
   PubMed Web of Science ®Google Scholar
• GREAVES DR, WANG W, DAIRAGHI DJ et al.: CCR6, a CC chemokine receptor that interacts with macrophage inflammatory protein 3a and is highly expressed in human dendritic cells. J. Exp. Med. (1997) 186:837–844.
   PubMed Web of Science ®Google Scholar
• YOSHIDA R, IMAI T, HIESHIMA K et al.: Molecular clon-ing of a novel human CC chemokine EBIl ligand che-mokine that is a specific functional ligand for EBH, CCR7. Biol. Chem. (1997) 272:13803–13809.
   Web of Science ®Google Scholar
• TIFFANY HL, LAUTENS LL, GAO J-L et al.: Identification ofCCR8: a human monocyte and thymus receptor for the CC chemokine 1-309. Exp. Med. (1997) 186:165–170.
   PubMed Web of Science ®Google Scholar
• ROOS RS, LOETSCHER M, LEGLER DF et al.: Identificationof CCR8, the receptor for the human CC chemokine I-309. J. Biol. Chem. (1997) 272:17251–17254.
   PubMed Web of Science ®Google Scholar
• HIESHIMA K, IMAI T, BABA M et al.: A novel human CC chemokine PARC that is most homologous to macrophage-inflammatory protein- la/LD78a and chemotactic for T lymphocytes, but not for mono-cytes. J. Immunol. (1997) 159:1140–1149.
   PubMed Web of Science ®Google Scholar
• ADEMA GJ, HARTGERS F, VERSTRATEN R et al.: A den-dritic cell-derived C-C chemokine that preferentially attracts naive T cells. Nature (1997) 387:713–717.
   PubMed Web of Science ®Google Scholar
• HROMAS R, KIM CH, KLEMSZ M et al.: Isolation and char-acterization of Exodus-2, a novel C-C chemokine with a unique 37-amino acid carboxy-terminal extension. J. Immunol. (1997) 159:2554–2558.
   PubMed Web of Science ®Google Scholar
• NAGIRA M, IMAI T, HIESHIMA K et al.: Molecular cloning of a novel human CC chemokine secondary lymphoid-tissue chemokine that is a potent chemoat-tractant for lymphocytes and mapped to chromosome 9p13. Biol. Chem. (1997) 272:19518–19524.
   Web of Science ®Google Scholar
• VICARI AP, FIGUEROA DJ, HEDRICK JA et al.: TECK: a novel CC chemokine specifically expressed by thymic dendritic cells and potentially involved in T-cell devel-opment. Immunity (1997) 7:291–301.
   PubMed Web of Science ®Google Scholar
• SCHULZ KNAPPE P, MAGERT HJ, DEWALD B et al.: HCC-1, a novel chemokine from human plasma. .1 Exp. Med. (1996) 183:295–299.
   Google Scholar
• MOHAMADZADEH M, POLTORAK AN, BERGSTRESSOR PR, BEUTLER B, TAKASHIMA A: Dendritic cells produce macrophage inflammatory protein-1 gamma, a new member of the CC chemokine family. .1 Immunol. (1996) 156:3102–3106.
   PubMed Web of Science ®Google Scholar
• CHANG M, MCNINCH J, ELIAS C, III et al.: Molecular clon-ing and functional chracterization of a novel CC che-mokine, stimulated T cell chemotactic protein (STCP-1) that specifically acts on activated T lympho-cytes. J. Biol. Chem. (1997) 272:15229–25237.
   Google Scholar
• GODISKA R, CHANTRY D, RAPORT CJ et al.: Human macrophage-derived chemokine (MDC), a novel che-moattractant for monocytes, monocyte-derived den-dritic cells and natural killer cells. .1 Exp. Med. (1997) 185:1595–1604.
   Google Scholar
• NARUSE K, UENO M, SATOH T et al.: A YAC contig of the human CC chemokine genes clustered on chromo-some 17q11.2. Genomics (1996) 34:236–240.
   Google Scholar
• HASKILL S, PEACE A, MORRIS J et al.: Identification of three related human GRO genes encoding cytokine functions. Proc. Natl. Acad. Sci. USA (1990) 87:7732–7736.
   PubMed Web of Science ®Google Scholar
• WALZ A, BURGENER R, CAR B et al.: Structure andneutrophil-activating properties of a novel inflamma-tory peptide (ENA-78) with homology to interleukin 8. .1 Exp. Med (1991) 174:1355–1362.
   Google Scholar
• ROVAI LE, HERSCHMAN HR, SMITH JB: Cloning and characterization of the human granulocyte chemotac-tic protein-2 gene. J. Immunol. (1997) 158:5257–5266.
   PubMed Web of Science ®Google Scholar
• FROYEN G, PROOST P, RONSSE I et al.: Cloning, bacterialexpression and biological characterization of recom-binant human granulocyte chemotactic protein-2 and differential expression of granulocyte chemotactic protein-2 and epithelial cell-derived neutrophil acti-vating peptide-78 mRNAs. Eur. J. Biochem. (1997) 243:762–769.
   PubMedGoogle Scholar
• TAUB DD, LLOYD AR, CONLON K et al Recombinant human interferon-inducible protein 10 is a chemoat-tractant for human monocytes and T-lymphocytes and promotes T-cell adhesion to endothelial cells. J. Exp. Med. (1993) 177(6):1809–1814.
   PubMed Web of Science ®Google Scholar
• LOETSCHER M, GERBER B, LOETSCHER P et al.: Che-mokine receptor specific for IP-10 and Mig: structure, function and expression in activated T-lymphocytes. J. Exp. Med. (1996) 184:963–969.
   PubMed Web of Science ®Google Scholar
• LIAO F, RABIN RL, YANNELLI JR et al.: Human Mig che-mokine: biochemical and functional characterization. Exp. Med. (1995) 182:1301–1314.
   PubMed Web of Science ®Google Scholar
• RANI MRS, FOSTER GR, LEUNG S et al.: Characterization of l3-R1, a gene that is selectively induced by interferon 13 (IFN-13) compared with IFN-a. J. Biol. Chem. (1996) 271:22878–22884.
   PubMed Web of Science ®Google Scholar
• BLEUL CC, FUHLBRIGGE RC, CASASNOVAS JM, AIUTI A, SPRINGER TA: A highly efficacious lymphocyte che-moattractant, stromal cell-derived factor 1 (SDF-1). J. Exp. Med. (1996) 184:1101–1110.
   PubMed Web of Science ®Google Scholar